These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 37850781)

  • 1. Volume of distribution as an early predictor of vancomycin-induced AKI in critically ill patients.
    Ghasemiyeh P; Vazin A; Zand F; Mohammadi-Samani S
    Acta Biomed; 2023 Oct; 94(5):e2023185. PubMed ID: 37850781
    [No Abstract]   [Full Text] [Related]  

  • 2. Comparative Incidence of Acute Kidney Injury in Critically Ill Patients Receiving Vancomycin with Concomitant Piperacillin-Tazobactam or Cefepime: A Retrospective Cohort Study.
    Hammond DA; Smith MN; Painter JT; Meena NK; Lusardi K
    Pharmacotherapy; 2016 May; 36(5):463-71. PubMed ID: 26952639
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Incidence and risk factors of acute kidney injury associated with continuous intravenous high-dose vancomycin in critically ill patients: A retrospective cohort study.
    Lacave G; Caille V; Bruneel F; Palette C; Legriel S; Grimaldi D; Eurin M; Bedos JP
    Medicine (Baltimore); 2017 Feb; 96(7):e6023. PubMed ID: 28207512
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Piperacillin/Tazobactam and Antibiotic-Associated Acute Kidney Injury in Critically Ill Children.
    Joyce EL; Kane-Gill SL; Priyanka P; Fuhrman DY; Kellum JA
    J Am Soc Nephrol; 2019 Nov; 30(11):2243-2251. PubMed ID: 31501354
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vancomycin-Associated Acute Kidney Injury in Critically Ill Adolescent and Young Adult Patients.
    Hays WB; Tillman E
    J Pharm Pract; 2020 Dec; 33(6):749-753. PubMed ID: 30808269
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acute kidney injury during vancomycin therapy in critically ill children.
    Totapally BR; Machado J; Lee H; Paredes A; Raszynski A
    Pharmacotherapy; 2013 Jun; 33(6):598-602. PubMed ID: 23526674
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vancomycin/Piperacillin-tazobactam Nephrotoxicity in the Critically Ill.
    Kollef MH; Juang P; Micek ST
    Clin Infect Dis; 2020 Mar; 70(7):1520-1521. PubMed ID: 31297504
    [No Abstract]   [Full Text] [Related]  

  • 8. Vancomycin-associated acute kidney injury in pediatric cardiac intensive care patients.
    Moffett BS; Hilvers PS; Dinh K; Arikan AA; Checchia P; Bronicki R
    Congenit Heart Dis; 2015; 10(1):E6-10. PubMed ID: 24934335
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Incidence of Acute Kidney Injury Among Critically Ill Patients With Brief Empiric Use of Antipseudomonal β-Lactams With Vancomycin.
    Schreier DJ; Kashani KB; Sakhuja A; Mara KC; Tootooni MS; Personett HA; Nelson S; Rule AD; Steckelberg JM; Tande AJ; Barreto EF
    Clin Infect Dis; 2019 Apr; 68(9):1456-1462. PubMed ID: 30165426
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Factors associated with vancomycin nephrotoxicity in the critically ill.
    Hanrahan TP; Kotapati C; Roberts MJ; Rowland J; Lipman J; Roberts JA; Udy A
    Anaesth Intensive Care; 2015 Sep; 43(5):594-9. PubMed ID: 26310409
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk of acute kidney injury associated with anti-pseudomonal and anti-MRSA antibiotic strategies in critically ill patients.
    Côté JM; Desjardins M; Cailhier JF; Murray PT; Beaubien Souligny W
    PLoS One; 2022; 17(3):e0264281. PubMed ID: 35271615
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Risk of Acute Kidney Injury in Critically Ill Patients Receiving Concomitant Vancomycin With Piperacillin-Tazobactam or Cefepime.
    Molina KC; Barletta JF; Hall ST; Yazdani C; Huang V
    J Intensive Care Med; 2020 Dec; 35(12):1434-1438. PubMed ID: 30741072
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Attributable nephrotoxicity of vancomycin in critically ill patients: a marginal structural model study.
    Arnaud FCS; Libório AB
    J Antimicrob Chemother; 2020 Apr; 75(4):1031-1037. PubMed ID: 31904834
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased Risk of Acute Kidney Injury in Critically Ill Children Treated With Vancomycin and Piperacillin/Tazobactam.
    Holsen MR; Meaney CJ; Hassinger AB; Fusco NM
    Pediatr Crit Care Med; 2017 Dec; 18(12):e585-e591. PubMed ID: 28906422
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Continuous Versus Intermittent Infusion of Vancomycin and the Risk of Acute Kidney Injury in Critically Ill Adults: A Systematic Review and Meta-Analysis.
    Flannery AH; Bissell BD; Bastin MT; Morris PE; Neyra JA
    Crit Care Med; 2020 Jun; 48(6):912-918. PubMed ID: 32317590
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Kidney Injury in Critically Ill Patients Treated with Vancomycin and Zosyn or an Alternative: A Systematic Review and Meta-Analysis.
    Blears EE; Morris J; Popp D; Lee JO; Norbury WB
    Surg Infect (Larchmt); 2022 Aug; 23(6):516-524. PubMed ID: 35736797
    [No Abstract]   [Full Text] [Related]  

  • 17. Impact of a vancomycin loading dose on the achievement of target vancomycin exposure in the first 24 h and on the accompanying risk of nephrotoxicity in critically ill patients.
    Hodiamont CJ; Juffermans NP; Berends SE; van Vessem DJ; Hakkens N; Mathôt RAA; de Jong MD; van Hest RM
    J Antimicrob Chemother; 2021 Oct; 76(11):2941-2949. PubMed ID: 34337660
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Incidence of Acute Kidney Injury Among Patients Receiving the Combination of Vancomycin with Piperacillin-Tazobactam or Meropenem.
    Robertson AD; Li C; Hammond DA; Dickey TA
    Pharmacotherapy; 2018 Dec; 38(12):1184-1193. PubMed ID: 30175410
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vancomycin-associated nephrotoxicity in the critically ill: a retrospective multivariate regression analysis*.
    Hanrahan TP; Harlow G; Hutchinson J; Dulhunty JM; Lipman J; Whitehouse T; Roberts JA
    Crit Care Med; 2014 Dec; 42(12):2527-36. PubMed ID: 25083977
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vancomycin with concomitant piperacillin/tazobactam vs. cefepime or meropenem associated acute kidney injury in the critically ill: A multicenter propensity score-matched study.
    Buckley MS; Komerdelj IA; D'Alessio PA; Rangan P; Agarwal SK; Tinta NC; Martinez BK; Ziadat DS; Yerondopoulos MJ; Kobic E; Kane-Gill SL
    J Crit Care; 2022 Feb; 67():134-140. PubMed ID: 34768175
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.